Low-Dose Naltrexone in Diseases' Treatment: Global Review

Anxiolytics, adrenergic agents, and naltrexone

J Am Acad Child Adolesc Psychiatry
May 1999
https://pubmed.ncbi.nlm.nih.gov/10230186/

Etiological Pathways Toward Autism and Diversities of Treatments: From Unimodal to Multidimensional Approaches

Neuropsychoanalysis
February 2016
http://www.tandfonline.com/doi/abs/10.1080/15294145.2016.1156388

Naltrexone in young autistic children: replication study and learning measures

J Am Acad Child Adolesc Psychiatry
November 1997
https://www.ncbi.nlm.nih.gov/pubmed/?term=19393386

Objective: This study expanded upon previous work on naltrexone efficacy and safety in young autistic children and assessed performance on learning measures.

Treatment of a serious autistic disorder in a child with Naltrexone in an oral suspension form
     in French

Encephale
April 2009
https://www.ncbi.nlm.nih.gov/pubmed/?term=19393386

Opioid-immune interactions in autism: behavioural and immunological assessment during a double-blind treatment with naltrexone

Ann Ist Super Sanita
1996
https://www.ncbi.nlm.nih.gov/pubmed/?term=9028057

Novel and emerging treatments for autism spectrum disorders: a systematic review

Ann Clin Psychiatry
Oct-Dec 2009
https://www.ncbi.nlm.nih.gov/pubmed/?term=19917212

The effects of chronic naltrexone treatment in young autistic children: a double-blind placebo-controlled crossover study

Biol Psychiatry
June 1996
https://www.ncbi.nlm.nih.gov/pubmed/?term=8780837

Psychopharmacology of aggression in children and adolescents with autism: a critical review of efficacy and tolerability

J Child Adolesc Psychopharmacol
April 2008
https://www.ncbi.nlm.nih.gov/pubmed/?term=18439113

Naltrexone in young autistic children: a double-blind, placebo-controlled crossover study

J Am Acad Child Adolesc Psychiatry
February 1995
https://www.ncbi.nlm.nih.gov/pubmed/7896655

Objective: This study evaluated the efficacy and safety of naltrexone, an opiate blocker, in the treatment of autism.